Home Pregnancy Test Evaluation Study

November 8, 2018 updated by: SPD Development Company Limited

This study will evaluate consumer preference and consumer results from a number of commercially available home pregnancy tests.

The study is being conducted as a formal assessment home pregnancy tests sold in Western Europe.

Study Overview

Status

Completed

Conditions

Detailed Description

The study will be conducted in two parts:

Part 1: Volunteers representative of pregnancy test users will use a range (4 of 7 different tests being evaluated) in their own home to gain usability data. All products will be used according to their instructions for use which, where required, will be translated into English prior to the study start. A study questionnaire will be completed after each test is used.

Part 2: The volunteers will attend the study site soon after completing their last home test and be required to read randomised results of tests conducted by study technicians (pregnant and not pregnant) to gain an understanding of their ability to correctly read results of the tests. The technician will also read and record the test results to enable both the laboratory agreement (technician read) and the consumer readability to be determined and compared for each product.

Each volunteer will be required to provide a urine sample for determining pregnancy status and quantitative urinary hormone measurement (this is done to confirm the result obtained at home using the HPTs).

At the end of the testing period the volunteers will also be asked to rank the four products they have used in the study, based on a series of statements regarding usability and readability of the tests

Study Type

Interventional

Enrollment (Actual)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bedfordshire
      • Bedford, Bedfordshire, United Kingdom, MK44 3UP
        • SPD Development company Ltd.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 43 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female
  • Aged 18-45 years
  • Willing to give informed consent
  • Willing to conduct a personal home pregnancy test and reveal their pregnancy status

Exclusion Criteria:

  • Currently or previously employed by SPD, Alere, Unipath, P&G, Abbott, or affiliates
  • Has an immediate relative* currently or previously employed by SPD, Alere, Unipath, P&G, Abbott or affiliates
  • Taken a hormonal preparation containing hCG in the last month, e.g. Pregnyl®
  • Recently miscarried and yet to have 2 complete menstrual cycles before study start

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: pregnancy test
pregnancy tests
Each participant will use 4 different home pregnancy tests

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
1. Demonstration of volunteer preference for a HPTs.
Time Frame: 1 week
• The cumulative scores on a 7-point likert scale for ease of use questions on the device usability at home questionnaire, where 1 equals very good and 7 equals very poor for each attribute.
1 week
2. Demonstration of volunteer readability of HPTs
Time Frame: 1 week
• The cumulative scores on a 7-point likert scale for readability questions on the device readability at SPD questionnaire, where 1 equals very easy and 7 equals very difficult for each attribute.
1 week
3. Demonstration of consumer preference for a HPT
Time Frame: 1 week
• The ranking of each Home Pregnancy Test in order of preference
1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
1. Accuracy of reading
Time Frame: 1 week
The per cent agreement (accuracy) between the result read by the volunteer and true result for each standard tested (i.e 0 hCG will be not pregnant and 25mIU/ml hCG will be pregnant) for each Home pregnancy test evaluated.
1 week
Agreement of reading
Time Frame: 1 week
The agreement between volunteer home pregnancy test results and those of a technician testing the same urine standard (volunteer vs. technician test result)
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 6, 2018

Primary Completion (Actual)

August 13, 2018

Study Completion (Actual)

August 13, 2018

Study Registration Dates

First Submitted

June 6, 2018

First Submitted That Met QC Criteria

July 4, 2018

First Posted (Actual)

July 18, 2018

Study Record Updates

Last Update Posted (Actual)

November 9, 2018

Last Update Submitted That Met QC Criteria

November 8, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • PROTOCOL-0972

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Testing

Clinical Trials on home pregnancy test

3
Subscribe